Sign up Australia
Proactive Investors - Run By Investors For Investors
Why invest in BRH?
Braveheart Investment Group: THE INVESTMENT CASE

Braveheart Investment gets more hands-on as portfolio grows

There’s a good chance one (or all) might end up being the future for Braveheart.
Spotting when an engine is going wrong is Gyrometric's skill

A change of strategy over the past year has seen Braveheart Investment Group PLC (LON:BRH) focus on its three key portfolio companies – Kirkstall, Paraytec and Gyrometric Systems.

The investment company now also works much more closely with the boards of all three companies.

Trevor Brown, chief executive, told Proactive there’s a good chance one (or all) might end up being the future for Braveheart.


Imaging detector specialist Paraytec – a spin–out from York University’s chemistry department – has developed a scientific grade electronic camera chip for pharmaceutical and biopharma companies to use as a research tool.  

Its accuracy means the camera can pick out particles in a fluid and even potentially spot bladder cancer cells in urine, an area of significant interest currently.

Potentially, this might save the NHS millions especially as the aim is to shrink the technology down to smartphone size so eventually people will be able to self-test before going to seek further treatment.

Alzheimer’s is another possible area as the camera can spot a biomarker in the blood associated with the brain disease.

Braveheart has 42% stake, but this will be reduced by a £4mln fundraising in July where it did not participate.

“The [July] funds will be used to complete the development programme and conduct the clinical study required to obtain the necessary regulatory approvals and commercialise the test,” said Brown.


Gyrometric – spun out of Nottingham University– is already generating revenues from its rotating shaft, vibration detection software.

Making this information digital enables it to be analysed faster and in much greater detail, which is critical when it comes to protecting large items of capital equipment such as a ship engine.

Icebreakers, for example, have very expensive drive mechanisms. The software developed by Gyrometrics identifies a potential problem very quickly and shuts down the drive enabling it to be remedied on the spot rather having to go to a shipyard.

Some 49 marine systems have already been delivered, with offshore wind (a €27bn market) and nuclear power stations the next targets.

Braveheart owns more than 50% of Gyrometric.


Kirkstall’s organ on a chip technology is used to improve the efficiency of drugs pipelines and to spot the next potential blockbuster drugs.

Seventy universities already use it and interest is now growing from the pharma sector, with eight companies said to be evaluating the technology.

A distribution agreement was set up for the US with Lonza in 2016 and Kirkstall recently raised £2.5mln to support both this agreement and to develop more applications.

Braveheart retains a significant holding in Kirkstall (38%),

Fund management

Steady income is provided by the wholly-owned subsidiary, Viking Fund Managers.

Viking's main fund management income comes from a contract with the Finance Yorkshire Equity Fund, but it also provides specialist fund management services to other funds that are in 'run-out' mode. 

Profits nearly double

The AIM-listed fund manager reported pre-tax profits for the year to March of £1.49mln, up from £0.78mln the previous year, while its cash at bank stood at £1.13mln, from £1.42mln the year before.

The group added that its portfolio had a valuation at the end of its financial year of £2.22mln, up from £862,000 the year before, owing to “considerable operational progress” in its strategic investment and a recent revaluation of its portfolio.

View full BRH profile View Profile

Braveheart Investment Group Timeline

Related Articles

June 27 2018
The mineral resources investor thinks the macroeconomic environment is favourable to the mining sector. It has four investments that over the next 18 months or so could see it repeat the success it had with its investment in the Prognoz silver project in Russia.
July 12 2018
There’s a good chance one (or all) might end up being the future for Braveheart.

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use